中文 | English
订货电话
400-1683301
800-8283301
电话订货时间:
工作日9:00-17:00
订货邮件
order@beyotime.com
订货QQ
4001683301
微信在线咨询
订单下载
碧云天订单.xls
抗体> 二抗> 荧光标记二抗
Alexa Fluor 555标记驴抗小鼠IgG(H+L)
产品编号: A0460
产品包装:100μl
选择包装
价格: ¥ 483.00
产品简介
使用说明
产品文件
相关产品
相关论文
产品问答
产品编号 产品名称 产品包装 产品价格
A0460 Alexa Fluor 555标记驴抗小鼠IgG(H+L) 100μl 483.00元

本Alexa Fluor 555标记驴抗小鼠IgG(H+L)(Alexa Fluor 555-labeled Donkey Anti-Mouse IgG(H+L))为进口分装,用于免疫荧光染色。
Alexa Fluor 555是一种常用的非常明亮的红色荧光探针。它比绝大部分常用的红色荧光探针更加明亮,更加不容易淬灭,而且背景更低。Alexa Fluor 555的荧光光谱和Cy3非常接近。Alexa Fluor 555的吸收(激发)和发射峰参见下表。

Fluorophore Absorption Peak (nm) Emission Peak (nm)
Alexa Fluor 555 555 565

本抗体为用纯化的小鼠IgG免疫驴,然后用亲和纯化柱对获得的抗血清进行纯化,并经过人IgG、兔IgG和大鼠IgG吸附纯化的优质二抗。
本Alexa Fluor 555标记驴抗小鼠IgG(H+L)用于免疫荧光染色时的推荐稀释比例为1:500。实际实验操作过程中需根据抗原和抗体的具体情况适当调节荧光标记二抗的稀释比例,推荐的调节范围为1:200-1000。
本抗体如果用于常规的免疫染色,以每次检测需1毫升1:500稀释的荧光标记二抗计,至少可以检测50次。如果适当重复使用已经使用过的荧光标记二抗,至少可以多检测150-250次。
包装清单:

产品编号 产品名称 包装
A0460 Alexa Fluor 555标记驴抗小鼠IgG (H+L) 100μl
说明书 1份

保存条件:
-20℃避光保存,一年有效。
注意事项:
本产品仅限于专业人员的科学研究用,不得用于临床诊断或治疗,不得用于食品或药品,不得存放于普通住宅内。
为了您的安全和健康,请穿实验服并戴一次性手套操作。

使用说明:
1. 免疫荧光染色请参考相关实验步骤进行。起始稀释浓度按照产品简介中推荐的稀释比例进行稀释。
2. 如果希望重复使用稀释的荧光标记二抗,稀释的荧光标记二抗4℃保存。
物质安全数据单
输入右侧验证码点击下载:
更换校验码
质检证书
输入批号搜寻COA
搜索
相关产品请点击如下按钮:
使用本产品的文献:
1. Zhenxing Song, Jiamei Lin, Rui Su, Yu Ji, Ruirui Jia, Shi Li, Ge Shan, Chuan Huang
.
Nucleic Acids Res. 2022 Nov 11;50(20):11529-11549. doi: 10.1093/nar/gkac980. (IF 11.501)
2. Zhao H, Chen Y, Shao L, Xie M, Nie J, Qiu J, Zhao P, Ramezani H, Fu J, Ouyang H, He Y
.
Small. 2018 Sep;14(39):e1802630. (IF 11.459)
3. Jiao Wang, Qiong Huang, Xingbin Hu, Shuyi Zhang, Yu Jiang, Guangyu Yao, Kongzhen Hu, Xin Xu, Bishan Liang, Qijing Wu, Zhenfeng Ma, Yawen Wang, Chunlin Wang, Zhenzhen Wu, Xiaoxiang Rong, Wangjun Liao, Min Shi
.
Cancer Res. 2022 Apr 15;82(8):1503-1517. doi: 10.1158/0008-5472.CAN-21-1820. (IF 9.727)
4. Shuang Qiao, Wenhua Lu, Christophe Glorieux, Jiangjiang Li, Peiting Zeng, Ning Meng, Huiqin Zhang, Shijun Wen, Peng Huang
.
Oncogene. 2021 Sep;40(39):5880-5892. doi: 10.1038/s41388-021-01968-2. (IF 7.971)
5. Li F, Yang X, Liu J, Shu K, Shen C, Chen T, Yang W, Li S, Wang X, Jiang M
.
MOL THER-NUCL ACIDS. 2019 Jun 7 16:295-301. (IF 7.032)
6. Xiao T, Zhong W, Zhao J, Qian B, Liu H, Chen S, Qiao K, Lei Y, Zong S, Wang H, Liang Y, Zhang H, Meng J, Zhou H, Sun T, Liu Y, Yang C
.
Cell Death Dis. 2018 Sep 5;9(9):906. (IF 6.304)
7. Mengyun Wang, Yue Du, Song Gao, Zheng Wang, Pengxiang Qu, Yang Gao, Jingyi Wang, Zhengqi Liu, Jingcheng Zhang, Yong Zhang, Suzhu Qing, Yongsheng Wang
.
Development. 2021 Mar 5;148(5):dev189670. doi: 10.1242/dev.189670. (IF 5.611)
8. Chuanyu Zhang, Hang Wen, Siying Liu, Enze Fu, Lu Yu, Shang Chen, Qingsheng Han, Zongjin Li, Na Liu
.
Front Cell Dev Biol. 2022 Jun 3:10:882671. doi: 10.3389/fcell.2022.882671. (IF 5.201)
9. Shan Qiao, Quan-Ye Sun, Peng Zhou, Shan-Chao Zhang, Zhi-Hao Wang, Hai-Yun Li, Ai-Hua Wang, Xue-Wu Liu, Tao Xin
.
Front Immunol. 2022 Dec 8:13:1046778. doi: 10.3389/fimmu.2022.1046778. (IF 5.085)
10. Guan Y, Guo L, Yang E, Liao Y, Liu L, Che Y, Zhang Y, Wang L, Wang J, Li Q.
.
Virology. 2014 Jul 15;464-465C:1-10. (IF 2.819)
11. Dong WL, Hou CC, Yang WX.
.
Cell Tissue Res. 2015 Feb;359(2):679-92. (IF 4.044)
12. Hu L, Su C, Song X, Shi Q, Fu J, Xia X, Xu D, Song E, Song Y.
.
Neurotoxicology. 2015 Jul;49:149-57. (IF 3.105)
15. Shen HQ, Xiao YX, She ZY, Tan FQ, Yang WX.
.
Exp Cell Res. 2017 Mar 1;352(1):95-103. (IF 3.383)
16. Qu P, Qing S, Liu R, Qin H, Wang W, Qiao F, Ge H, Liu J, Zhang Y, Cui W, Wang Y.
.
PLoS One. 2017 Mar 28;12(3). (IF 2.74)
17. Luo C, Chen S, Xu N, Sai WB, Zhao W, Li YC, Hu XJ, Tian H, Gao XD, Yao WB.
.
Biomed Pharmacother. 2017 Apr;88:87-94. (IF 4.545)
18. Guo J, Cai H, Zheng J, Liu X, Liu Y, Ma J, Que Z, Gong W, Gao Y, Tao W, Xue Y.
.
BBA-BIOMEMBRANES. 2017 Sep;1863(9):2240-2254. (IF 3.411)
19. Xu Y, Li R, Zhang K, Wu W, Wang S, Zhang P, Xu H
.
BMB Rep. 2018 Jul;51(7):350-355. (IF 3.167)
20. Wu K, Zhang H, Fu Y, Zhu Y, Kong L, Chen L, Zhao F, Yu L, Chen X
.
Mol Med Rep. 2018 Sep;18(3):3411-3420. (IF 2.1)
21. Hua K, Li Y, Zhou H, Hu X, Chen Y, He R, Luo R, Zhou R, Bi D, Jin H
.
FRONT CELL INFECT MI. 2018 Sep 12;8:324. (IF 4.123)
22. Li, Wang H, Li Z, Wang C, Xiao F, Gao Y, Zhang X, Wang P, Peng J, Cai G, Zuo B, Shen Y, Qi J, Qian N, Deng L, Song W, Zhang X, Shen L, Chen X
.
BIOCHEM BIOPH RES CO. 2018 Sep 5;503(2):1115-1122. (IF 2.985)
23. Shen W, Jin Z, Tong X, Wang H, Zhuang L, Lu X, Wu S
.
Cancer Manag Res. 2019 Jun 24 11:5725-5735. (IF 2.886)
24. Mei Li, Di Zhang, Chuntian Li, Zifeng Zheng, Ming Fu, Fengfeng Ni, Yalan Liu, Tao Du, Hanzhong Wang, George E Griffin, Mudan Zhang, Qinxue Hu
.
Front Microbiol. 2020 Mar 6;11:242. doi: 10.3389/fmicb.2020.00242. (IF 4.235)
25. Minxia Ke, Meng Ji, Hao Wang, Yifeng Yao, Yuehong Wu, Nianmin Qi
.
Exp Ther Med. 2020 Mar;19(3):1701-1710. doi: 10.3892/etm.2020.8436. (IF 1.785)
26. Zhen-Yu She, Yue-Ling Li, Yang Lin, Ming-Hui Lu, Ya-Lan Wei, Kai-Wei Yu, Ning Zhong, Yu Xiao
.
BBA-MOL CELL RES. 2020 Apr;1867(4):118636. doi: 10.1016/j.bbamcr.2019.118636. (IF 4.105)
27. Anzana Parvin, Shuang-Li Hao, Fu-Qing Tan, Wan-Xi Yang
.
Gene. 2020 Nov 15;760:144989. doi: 10.1016/j.gene.2020.144989. (IF 2.984)
28. Hao Li, Pengfei Cui, Xue Fu, Lan Zhang, Wenjun Yan, Yaru Zhai, Changwei Lei, Hongning Wang, Xin Yang
.
BMC Genomics. 2021 Jan 20;22(1):67. doi: 10.1186/s12864-020-07359-3. (IF 3.594)
29. Xuechao Jiang, Tingting Li, Bojian Li, Wei Wei, Fen Li, Sun Chen, Rang Xu, Kun Sun
.
Clin Sci (Lond). 2021 Mar 26;135(6):829-846. doi: 10.1042/CS20201496.
30. Zhen-Yu She, Kai-Wei Yu, Ya-Lan Wei, Ning Zhong, Yang Lin
.
Cell Tissue Res. 2021 Mar;383(3):1167-1182. doi: 10.1007/s00441-020-03341-3. (IF 4.044)
31. Xinming Gao, Chen Du, Xuebin Zheng, Junquan Zhu, Shan Jin
.
J Morphol. 2021 Apr;282(4):500-510. doi: 10.1002/jmor.21323. (IF 1.563)
32. Jing-Wei Xing, Man-Man Chen, Xin-Yun Tian, Dan-Qing Pan, Xiu-Hua Peng, Peng-Fei Gao
.
Biomed Pharmacother. 2021 Jun;138:111455. doi: 10.1016/j.biopha.2021.111455. (IF 4.545)
33. Wenqi Shan, Weiyue Hu, Ya Wen, Xingwang Ding, Xuan Ma, Wu Yan, Yankai Xia
.
Reprod Toxicol. 2021 Aug;103:149-158. doi: 10.1016/j.reprotox.2021.06.009. (IF 3.121)
34. Hui Ma, Zeng-Chun Hu, Yu Long, Li-Chun Cheng, Chen-Yang Zhao, Ming-Kun Shao
.
Am J Chin Med. 2022;50(7):1845-1868. doi: 10.1142/S0192415X22500781.
35. Weiping Li, Mengying Mao, Nan Hu, Jia Wang, Jing Huang, Shensheng Gu
.
FEBS Open Bio. 2022 Jan;12(1):270-284. doi: 10.1002/2211-5463.13336. (IF 2.231)
36. Haixia Xu, Jiahua Guo, Wei Wu, Qiu Han, Yueru Huang, Yaling Wang, Cencen Li, Xiaofang Cheng, Pengpeng Zhang, Yongjie Xu
.
Cells. 2022 Apr 9;11(8):1277. doi: 10.3390/cells11081277. (IF 4.366)
37. Ya-Lan Wei, Xiao-Jing Fan, Yu-Ying Diao, Zhen-Yu She, Xin-Rui Wang
.
Exp Cell Res. 2022 May 1;414(1):113095. doi: 10.1016/j.yexcr.2022.113095. (IF 3.383)
38. Xuan Li, Sen Zhu, Zheng Li, Yu-Qi Meng, Su-Jie Huang, Qi-Yao Yu, Bin Li
.
Free Radic Res. 2022 May-Jun;56(5-6):398-410. doi: 10.1080/10715762.2022.2131551.
39. Rong Liang, Ling Wang, Shufan Sun, Chenguang Zheng, Jiajia Yang, Dong Ming
.
Life Sci Space Res (Amst). 2022 May:33:21-32. doi: 10.1016/j.lssr.2022.02.001.
40. Jia Xu, Xi Li, Purong Zhang, Jie Luo, Exian Mou, Shiwei Liu
.
Oncol Lett. 2022 May;23(5):147. doi: 10.3892/ol.2022.13268. (IF 2.311)
41. Wenlong Zhang, Qing Zhang, Nanfei Yang, Qian Shi, Huifang Su, Tingsheng Lin, Zhonglei He, Wenxin Wang, Hongqian Guo, Pingping Shen
.
Cancer Commun (Lond). 2022 Jun;42(6):536-557. doi: 10.1002/cac2.12311.
42. Kaifei Chu, Niannian Zhao, Xudong Hu, Rong Feng, Li Zhang, Ganglin Wang, Wei Li, Lin Liu
.
Biochem Biophys Res Commun. 2022 Aug 27:618:8-14. doi: 10.1016/j.bbrc.2022.06.029.
购物车
会员
顶部